Maple syrup urine disease metabolites studies in cerebellum cultures.
D000818:Animals; D000831:Animals, Newborn; D002531:Cerebellum / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D046508:Culture Techniques; D006801:Humans; D007532:Isoleucine / Q000378:metabolism / Q000494:pharmacology*; D007651:Keto Acids / Q000494:pharmacology*; D007930:Leucine / Q000378:metabolism / Q000494:pharmacology*; D008375:Maple Syrup Urine Disease / Q000378:metabolism*; D009186:Myelin Sheath / Q000187:drug effects; D009457:Neuroglia / Q000187:drug effects; D009474:Neurons / Q000187:drug effects; D051381:Rats; D013997:Time Factors; D014633:Valine / Q000378:metabolism / Q000494:pharmacology*
D007651:Keto Acids; D007532:Isoleucine; D007930:Leucine; D014633:Valine